Admedus is continuing with its planned divestiture of the Immunotherapies business which involves Star Bright (or a related party of Star Bright) investing $18.0 million into the business for a 60% stake. An additional $500,000 advance was received during the quarterfrom Star Bright (cumulative total of $1,000,000) which is intended to be offset against the proposed $18.0 million consideration.
So maybe they receiving some money into immuno from Star Bright
Admedus is continuing with its planned divestiture of the...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |